Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Netilmicin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,846Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Wuxi Fortune Pharmaceutical
    China
    		 Samjin Pharmaceutical Co., Ltd. 20210615-210-J-411(4) netilmicin sulfate 2022-09-27 WuXi Fortune Pharmaceutical Co.,Ltd China No. 2 Rongyang 1st Road, Wuxi City, China
    29/11/2025 Wuxi Fortune Pharmaceutical
    China
    		 Lee Yeon Pharmaceutical Co., Ltd. 20210615-210-J-411(2) netilmicin sulfate 2022-04-28 WuXi Fortune Pharmaceutical Co.,Ltd China No. 2 Rongyang 1st Road, Wuxi City, China